The purpose of this study is to understand whether the pharmacokinetics of tacrolimus is influenced by the concurrent use of sirolimus.
The controlled clinical trial held in NTUH in 2001 revealed that the bioavailability of tacrolimus when combined with sirolimus is lower than that reported in the literature where tacrolimus was not combined with sirolimus. To determine if the difference was due to the drug interaction between sirolimus and tacrolimus, a controlled clinical trial was proposed. The purpose of this study is to understand whether the pharmacokinetics of tacrolimus is influenced by the concurrent use of sirolimus.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
40
National Taiwan University Hospital
Taipei, Taiwan
RECRUITINGThe influence of sirolimus on the pharmacokinetics of tacrolimus in renal transplant patients
Compare the outcome of tacrolimus/sirolimus and tacrolimus/mycophenolate in rejection prevention
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.